ENVUE MEDICAL INC NEW
FEED
FEED was delisted on the 15th of September, 2026.
5 hedge funds and large institutions have $9.5K invested in ENVUE MEDICAL INC NEW in 2025 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
25% more funds holding
Funds holding: 4 → 5 (+1)
2.29% less ownership
Funds ownership: 2.45% → 0.15% (-2.3%)
47% less capital invested
Capital invested by funds: $18.1K → $9.5K (-$8.58K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$6.68K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.98K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$90 |
| 4 |
SS
SBI Securities
Tokyo,
Japan
|
+$90 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$10K |
| 2 |
Citigroup
New York
|
-$1.9K |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$1 |
FEED Hedge Fund Activity: Q3 2025 in Review
5 of the 7,642 institutional investors tracked by Wall St. Rank reported a position in ENVUE MEDICAL INC NEW (FEED) for Q3 2025, worth a combined $9.5K — down 47% from $18.1K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new FEED positions and 1 closed out — a net gain of 1 holder — while 2 added to existing stakes and 1 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $6.68K. The largest seller was UBS Group, cutting an estimated $10K.
- 5 institutional investors held ENVUE MEDICAL INC NEW (FEED) as of Q3 2025, up from 4 in Q2 2025.
- Funds reported $9.5K of ENVUE MEDICAL INC NEW stock for Q3 2025, down 47% quarter-over-quarter.
- 2 funds opened new ENVUE MEDICAL INC NEW positions in Q3 2025 and 1 closed out, a net change of +1 holder.
- The largest ENVUE MEDICAL INC NEW buyer in Q3 2025 was Morgan Stanley, an estimated $6.68K added.
- The largest ENVUE MEDICAL INC NEW seller in Q3 2025 was UBS Group, an estimated $10K sold.
Based on aggregated 13F filings for Q3 2025.